Annual report [Section 13 and 15(d), not S-K Item 405]

Related Parties (Tables)

v3.26.1
Related Parties (Tables)
 12 Months Ended
Dec. 31, 2025
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions The following tables summarize the Company’s transactions with Atrio:
Year Ended December 31,
2025 2024
(in thousands)
Capitated revenue $ 223,357  $ 303,606 
Other revenue $ 3,904  $ 4,340 
Medical expense $ 281,648  $ 345,566 
December 31,
2025 2024
(in thousands)
Health plan receivable $ 12,693  $ 23,872 
Claims payable $ 101,180  $ 61,090 
Health plan settlements payable $ 2,409  $ 1,386 
Deferred revenue (1)
$ —  $ — 
__________________
(1)Amount is included within accrued expenses and other current liabilities on the Company’s consolidated balance sheet.
The following tables summarize the Company’s transactions with VGS, VGS 2, VGS 3, VGS 4 and VGS 5:
Year Ended December 31,
2025 2024
(in thousands)
Interest expense, net $ 30,682  $ 9,025 
December 31,
2025 2024
(in thousands)
Long-term debt, net $ 156,722  $ 78,816 
In connection with the issuances of promissory notes to VGS, VGS 3, VGS 4, and VGS 5, the Company issued equity-classified warrants to purchase a total of 4.9 million shares of Class A common stock, as adjusted for the reverse
stock split. The warrants are described further in Note 13. The Company issued warrants to purchase a total of 3.5 million and 1.4 million shares of Class A common stock during the years ended December 31, 2025 and 2024, respectively.